Vikas Garg

613 total citations
36 papers, 419 citations indexed

About

Vikas Garg is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Vikas Garg has authored 36 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Vikas Garg's work include Ovarian cancer diagnosis and treatment (5 papers), Soft tissue tumor case studies (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Vikas Garg is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Soft tissue tumor case studies (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Vikas Garg collaborates with scholars based in India, Canada and Taiwan. Vikas Garg's co-authors include Saurabh Agrawal, Praveen Kumar Tomar, Anurag Chaudhary, Pratibha Gupta, Suvarna G. Kini, Umesh Kumar Singh, Amrita Malik, Ankit Kumar, Prateek Pathak and Amit M. Oza and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes and Clinical Cancer Research.

In The Last Decade

Vikas Garg

31 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikas Garg India 10 151 73 57 46 41 36 419
Fatemeh Ahmadipour Malaysia 12 223 1.5× 136 1.9× 66 1.2× 49 1.1× 45 1.1× 19 546
Fei Yao China 12 170 1.1× 60 0.8× 40 0.7× 52 1.1× 40 1.0× 20 360
Li‐Yen Shiu Taiwan 12 217 1.4× 70 1.0× 24 0.4× 59 1.3× 26 0.6× 20 453
Sara Mohamed Naguib Abdel Hafez Egypt 14 141 0.9× 54 0.7× 45 0.8× 25 0.5× 36 0.9× 54 527
Prashasnika Gehlot United States 7 189 1.3× 144 2.0× 31 0.5× 50 1.1× 56 1.4× 10 538
Chunlei Xu China 15 219 1.5× 66 0.9× 54 0.9× 93 2.0× 58 1.4× 53 748
Seema Noor Germany 11 302 2.0× 62 0.8× 25 0.4× 25 0.5× 21 0.5× 13 518
Tülin Özkan Türkiye 12 212 1.4× 59 0.8× 39 0.7× 20 0.4× 17 0.4× 47 408
Ali H. El‐Bahrawy Egypt 10 179 1.2× 122 1.7× 37 0.6× 27 0.6× 47 1.1× 18 466
Tseng‐Hsi Lin Taiwan 13 187 1.2× 82 1.1× 21 0.4× 37 0.8× 35 0.9× 19 480

Countries citing papers authored by Vikas Garg

Since Specialization
Citations

This map shows the geographic impact of Vikas Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Garg more than expected).

Fields of papers citing papers by Vikas Garg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Garg. The network helps show where Vikas Garg may publish in the future.

Co-authorship network of co-authors of Vikas Garg

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Garg. A scholar is included among the top collaborators of Vikas Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Garg. Vikas Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Vikas & Amit M. Oza. (2025). Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?. Clinical Cancer Research. 31(11). 2073–2076.
2.
Paruthi, Sagar, et al.. (2025). Leveraging Silica Fume as a Sustainable Supplementary Cementitious Material for Enhanced Durability and Decarbonization in Concrete. Advances in Civil Engineering. 2025(1). 7 indexed citations
3.
4.
Dhani, Neesha C., Wang Li, Robert C. Grant, et al.. (2024). 763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Annals of Oncology. 35. S577–S578. 1 indexed citations
5.
6.
Garg, Vikas, et al.. (2023). Carvacrol and its effect on cardiovascular diseases: From molecular mechanism to pharmacological modulation. Food Bioscience. 57. 103444–103444. 5 indexed citations
7.
Garg, Vikas, M. D. Ray, K.P. Haresh, et al.. (2023). Clinical Profile and Predictors of Survival in Carcinoma Penis Patients. Current Oncology. 30(5). 4563–4574. 3 indexed citations
8.
Garg, Vikas, et al.. (2023). Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose. European Journal of Cancer. 186. 142–150. 6 indexed citations
9.
Garg, Vikas & Amit M. Oza. (2023). Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options. Drugs. 83(15). 1365–1385. 33 indexed citations
10.
Garg, Vikas & Lalit Kumar. (2023). Metronomic chemotherapy in ovarian cancer. Cancer Letters. 579. 216469–216469. 5 indexed citations
11.
Malik, Prabhat Singh, Ranjit Kumar Sahoo, Surender K. Sharawat, et al.. (2023). Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution. Annals of Hematology. 102(8). 2087–2096. 7 indexed citations
12.
Garg, Vikas, Sameer Rastogi, Shamim Ahmed Shamim, et al.. (2022). Clinicopathological Profile and Outcomes of Anorectal Melanoma From a Tertiary Care Center in India. Future Science OA. 8(4). FSO786–FSO786. 3 indexed citations
13.
Garg, Vikas, et al.. (2022). Novel approaches for treatment of endometrial carcinoma. Current Problems in Cancer. 46(5). 100895–100895. 6 indexed citations
14.
Garg, Vikas, Sameer Rastogi, Sandeep Bhoriwal, et al.. (2022). Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosis. Supportive Care in Cancer. 30(12). 10089–10098. 8 indexed citations
15.
Garg, Vikas, et al.. (2021). Patient reported outcomes in patients with desmoid type fibromatosis.. Journal of Clinical Oncology. 39(15_suppl). 11574–11574. 3 indexed citations
16.
Seth, Tulika, Vikas Garg, Manoranjan Mahapatra, et al.. (2020). Efficacy of Single Low-Dose Rasburicase in Management of Tumor Lysis Syndrome in Leukemia and Lymphoma Patients. Clinical Lymphoma Myeloma & Leukemia. 21(1). e99–e104. 9 indexed citations
17.
Pushpam, Deepam, Vikas Garg, Sandip Ganguly, & Bivas Biswas. (2020). <p>Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects</p>. OncoTargets and Therapy. Volume 13. 5093–5112. 10 indexed citations
18.
Garg, Vikas, et al.. (2020). Managing Pediatric Cancer Patients in COVID19 Pandemic. The Indian Journal of Pediatrics. 87(7). 558–558.
19.
20.
Singh, Reema, et al.. (1990). Nutritional Intervention in Acute Myocardial Infarction. 1(3). 179–186. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatemeh Ahmadipour Breakdown of academic impact, for papers by Fei Yao Breakdown of academic impact, for papers by Li‐Yen Shiu Breakdown of academic impact, for papers by Sara Mohamed Naguib Abdel Hafez Breakdown of academic impact, for papers by Prashasnika Gehlot Breakdown of academic impact, for papers by Chunlei Xu Breakdown of academic impact, for papers by Seema Noor Breakdown of academic impact, for papers by Tülin Özkan Breakdown of academic impact, for papers by Ali H. El‐Bahrawy Breakdown of academic impact, for papers by Tseng‐Hsi Lin
Rankless by CCL
2026